Overview

U-LABA/ICS Effects on Exercise Performance, Vilanterol

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist vilanterol + fluticasone furoate
Phase:
N/A
Details
Lead Sponsor:
Morten Hostrup, PhD
Treatments:
Fluticasone
Xhance